Steder et al. analyzed data from the international genomics consortium expression project for oncology and observed that the loss of EPLIN expression is strongly associated with the metastatic behavior and tumor grading of prostate, colon, and head and neck cancer [10]. The gene discussed is LIMA1; the disease is neoplasm.